Our results suggest that ENZR PCa cells with low CAMK1D expression following C@HNA treatment remodel the immunosuppressive microenvironment by reprogramming multiple immune cell populations, which may enhance the efficacy of immune checkpoint inhibitors (ICIs) in these patients 28. Here, CAMK1D is linked to posterior cortical atrophy.